Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
复制标题
DOI:
10.1016/j.clcc.2011.03.001
复制
发表时间:
2011-06
影响因子:
3.4
通讯作者:
Venook AP
中科院分区:
文献类型:
--
作者:
Kelley RK;Venook AP
Conventional clinical and pathologic risk factors in stage II colon cancer provide limited prognostic information and do not predict response to adjuvant 5-fluorouracil-based chemotherapy. New prognostic and predictive biomarkers are needed to identify patients with highest recurrence risk who will receive the greatest absolute risk reduction from adjuvant chemotherapy. We review below the evidence for conventional risk factors in node-negative colon cancer patients, followed by a discussion of promising new molecular and genetic markers in this malignancy. Gene expression profiling is an emerging tool with both prognostic and predictive potential in oncology. For stage II colon cancer patients, the Oncotype DX Colon Cancer test is now commercially available as a prognostic marker, and the ColoPrint assay is expected to be released later this year. Current evidence for both of these assays is described below, concluding with a discussion of potential future directions for gene expression profiling in colon cancer risk stratification and treatment decision-making.
登录
查看更多内容
影响因子:
9
作者:
Croner, Roland S.;Foertsch, Thomas;Lausen, Berthold
通讯作者:
Lausen, Berthold
影响因子:
8.8
作者:
Bamford, S;Dawson, E;Forbes, S;Clements, J;Pettett, R;Dogan, A;Flanagan, A;Teague, J;Futreal, PA;Stratton, MR;Wooster, R
通讯作者:
Wooster, R
影响因子:
168.9
作者:
Gray, Richard;Barnwell, Jennifer;Kerr, David J.
通讯作者:
Kerr, David J.
影响因子:
45.3
作者:
Bertagnolli, Monica M.;Niedzwiecki, Donna;Redston, Mark
通讯作者:
Redston, Mark
影响因子:
45.3
作者:
Del Rio, Maguy;Molina, Franck;Ychou, Marc
通讯作者:
Ychou, Marc